Surya Jayaweera – Trademark Portfolio

Entity Type: 01

Surya Jayaweera holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include A, ACROPLIA, and MEET AWESOME. The owner is based in Claremont, CA.

622 Brigham Young Drive

Claremont, CA 91711

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Surya Jayaweera's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (6 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Surya Jayaweera have?

Surya Jayaweera has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 3 cancelled.

What trademark classes does Surya Jayaweera file in?

Surya Jayaweera files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Surya Jayaweera's most well-known trademarks?

Surya Jayaweera's registered trademark portfolio includes well-known marks such as A, ACROPLIA, and MEET AWESOME. These are among 3 currently registered trademarks in the portfolio.

What is Surya Jayaweera's trademark registration success rate?

Surya Jayaweera has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.